[CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT March 14, 2010 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co., Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 Section 3: Securities]
[1. Other Events FORM 6-K f6k_031611.htm 1 6-K]
[CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT March 14, 2010 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co., Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 Section 3: Securities]
[TPI 2010 Shareholder Annual Meeting on 3/21/11 to Be Held at 100 Wall Street, near NYSE TPI CHENGDU, China, March 17, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: The relocation is due to the most recent safety policy by NYSE that prevents any shareholder meetings to be arranged at NYSE. Shareholders who would like to attend the annual] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT March 17, 2010 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co., Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 Section 8: Other]
[TPI 2010 Shareholder Annual Meeting on 3/21/11 to Be Held at 100 Wall Street, near NYSE TPI CHENGDU, China, March 17, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: The relocation is due to the most recent safety policy by NYSE that prevents any shareholder meetings to be arranged at NYSE. Shareholders who would like to attend the annual] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT March 17, 2010 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co., Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 Section 8: Other]
[For further information contact: Lisa Jensen Vice President, Global Public Relations, Blizzard Entertainment 949.854.6200 dir 949.854.7900 fax ljensen@blizzard.com Rob Hilburger PR Director, Blizzard Entertainment 949.242.8404 dir 949.854.7900 fax rhilburger@blizzard.com Wu Wei PR Manager, NetEase 020-85106308 wuwei@corp.netease.com STARCRAFT OPEN BETA TESTING OF II IN MAINLAND CHINA STARTS ON MARCH29, 2011 SHANGHAI, China March18, 2011]
[For further information contact: Lisa Jensen Vice President, Global Public Relations, Blizzard Entertainment 949.854.6200 dir 949.854.7900 fax ljensen@blizzard.com Rob Hilburger PR Director, Blizzard Entertainment 949.242.8404 dir 949.854.7900 fax rhilburger@blizzard.com Wu Wei PR Manager, NetEase 020-85106308 wuwei@corp.netease.com STARCRAFT OPEN BETA TESTING OF II IN MAINLAND CHINA STARTS ON MARCH29, 2011 SHANGHAI, China March18, 2011]
[Mindray Appoints Mr.Jie Liu Chief Financial Officer Mr.Ronald Ede Will Remain With Mindray a Director SHENZHEN, China, March18 /PRNewswire-Asia-FirstCall/ Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the appointment of Mr. Jie Liu Chief Financial Officer (CFO)of thempany effective of April 30, 2011, succeeding Mr.Ronald]
[YEAR 2010 / 4 th QUARTER The following discussion of our financial condition and results of operations should be read in conjunction with the accompanying financial statements. Overview We are a leading business-to-business (B2B) media company and a primary facilitator of two-way trade with Greater China. The core business is facilitating trade from Greater China to the world, using a] [GLOBAL SOURCES LTD. AND SUBSIDIARIES At At December 31, December 31, 2010 2009 (Unaudited) ASSETS Current Assets: Cash and cash equivalents $ 101,298 $ 91,553 Term deposits with banks 1,411 60,357 Available-for-sale securities - 6,423 Accounts receivable, net 3,919 3,438 Receivables from sales representatives 8,248 5,607 Inventory 435 600] [GLOBAL SOURCES LTD. AND SUBSIDIARIES Three months ended Year ended December 31, December 31, 2010 2009 2010 2009 (Unaudited) (Unaudited) (Unaudited) (Unaudited) Revenue: Online and other media services (Note 1) $ 31,714 $ 27,788 $ 122,203 $ 113,775 29,896 25,775 69,450 55,147 Miscellaneous 1,399] [GLOBAL SOURCES LTD. AND SUBSIDIARIES Three months ended December 31, Year ended December 31, 2010 2009 2010 2009 U.S. GAAP Net Income Attributable to the Company $ 9,450 $ 8,636 $ 21,571 $ 16,110 IFRS conversion adjustments: Revenue]
[YEAR 2010 / 4 th QUARTER The following discussion of our financial condition and results of operations should be read in conjunction with the accompanying financial statements. Overview We are a leading business-to-business (B2B) media company and a primary facilitator of two-way trade with Greater China. The core business is facilitating trade from Greater China to the world, using a] [GLOBAL SOURCES LTD. AND SUBSIDIARIES At At December 31, December 31, 2010 2009 (Unaudited) ASSETS Current Assets: Cash and cash equivalents $ 101,298 $ 91,553 Term deposits with banks 1,411 60,357 Available-for-sale securities - 6,423 Accounts receivable, net 3,919 3,438 Receivables from sales representatives 8,248 5,607 Inventory 435 600] [GLOBAL SOURCES LTD. AND SUBSIDIARIES Three months ended Year ended December 31, December 31, 2010 2009 2010 2009 (Unaudited) (Unaudited) (Unaudited) (Unaudited) Revenue: Online and other media services (Note 1) $ 31,714 $ 27,788 $ 122,203 $ 113,775 29,896 25,775 69,450 55,147 Miscellaneous 1,399] [GLOBAL SOURCES LTD. AND SUBSIDIARIES Three months ended December 31, Year ended December 31, 2010 2009 2010 2009 U.S. GAAP Net Income Attributable to the Company $ 9,450 $ 8,636 $ 21,571 $ 16,110 IFRS conversion adjustments: Revenue]
